Katharine Peterson

Insider Reports History

Location
Watertown, MA
Signature
/s/ Adam D. Levy, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Katharine Peterson:

Company Role Class Num Shares Value Price $ Report Date Ownership
Acrivon Therapeutics, Inc. Chief Accounting Officer Common Stock 4,006 $6,529 $1.63 14 Feb 2026 Direct
Acrivon Therapeutics, Inc. Chief Accounting Officer Stock Option (Right to Buy) 31,900 01 Mar 2026 Direct

Insider Reports Filed by Katharine Peterson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACRV Acrivon Therapeutics, Inc. 01 Mar 2026 1 $0 4 Chief Accounting Officer 03 Mar 2026, 16:22
ACRV Acrivon Therapeutics, Inc. 14 Feb 2026 1 -$189 4 Chief Accounting Officer 18 Feb 2026, 16:14
ACRV Acrivon Therapeutics, Inc. 14 Nov 2025 1 -$222 4 Chief Accounting Officer 18 Nov 2025, 16:33
ACRV Acrivon Therapeutics, Inc. 14 Aug 2025 1 -$138 4 Chief Accounting Officer 18 Aug 2025, 17:19
ACRV Acrivon Therapeutics, Inc. 14 May 2025 1 -$113 4 Chief Accounting Officer 16 May 2025, 16:21
ACRV Acrivon Therapeutics, Inc. 01 Mar 2025 1 $0 4 Chief Accounting Officer 04 Mar 2025, 17:36
ACRV Acrivon Therapeutics, Inc. 14 Feb 2025 1 -$629 4 Chief Accounting Officer 19 Feb 2025, 17:00
ACRV Acrivon Therapeutics, Inc. 14 Nov 2024 1 -$784 4 Chief Accounting Officer 18 Nov 2024, 16:32
ACRV Acrivon Therapeutics, Inc. 14 Aug 2024 1 -$695 4 Chief Accounting Officer 16 Aug 2024, 16:53
ACRV Acrivon Therapeutics, Inc. 14 May 2024 1 -$828 4 Chief Accounting Officer 16 May 2024, 19:05
ACRV Acrivon Therapeutics, Inc. 13 May 2024 0 $0 3 Chief Accounting Officer 16 May 2024, 18:52